UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely BioLineRx is implementing good security practices.
BioLineRx, or BioLine, is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
This report shows a preliminary security rating for BioLineRx. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Third-party vendors are an important source of strategic advantage, cost savings and expertise. Yet ...
Email security refers to various cybersecurity measures to secure the access and content of an ...
Compare BioLineRx's security performance with other companies